Molecular regulators of defective placental and cardiovascular development in fetal growth restriction

Anandita Umapathy1, Alys Clark1,2, Arvind Sehgal3

  • 1Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, New Zealand.

Insights

Placental insufficiency causes fetal growth restriction (FGR), impacting fetal development and increasing later-life chronic disease risk. Understanding shared placental and heart development factors is crucial for FGR research.

Area of Science:

  • Obstetrics and Gynecology
  • Developmental Biology
  • Cardiovascular Science

Background:

  • Placental insufficiency is a primary cause of fetal growth restriction (FGR).
  • FGR leads to poor fetal growth and increased risks of chronic diseases later in life.
  • Placental and cardiac development are interconnected, suggesting FGR impacts heart development.

Purpose of the Study:

  • To review key molecular factors common to placental and cardiovascular development.
  • To understand their role in FGR and associated developmental defects.

Main Methods:

  • Literature review of growth factors, angiogenic molecules, and transcription factors.
  • Analysis of shared pathways in placental and cardiac development.

Main Results:

  • Identified key molecular players (growth factors, angiogenic molecules, transcription factors) implicated in both placental and cardiac development.
  • Highlighted their common role in FGR pathogenesis.

Conclusions:

  • Shared molecular mechanisms are critical in FGR, affecting both placental function and fetal heart development.
  • Targeting these shared pathways may offer therapeutic strategies for FGR and its long-term consequences.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
567